Charles J. Collins Insider Trading $LMNX LUMINEX CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Charles J. Collins.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Charles J. Collins. Charles J. Collins is SR VP, R&D - US in LUMINEX CORP ($LMNX).

Charles J. Collins in LUMINEX CORP

Trading Symbol: LMNX
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Charles J. Collins: SR VP, R&D - US
Holdings: 49,503 shares
Current Value: $920,756
Latest Transaction: Mar 17 2021
$LMNX Market Capitalization: $799.33M
$LMNX Previous Close: $18.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Charles J. Collins in LUMINEX CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 17 2021LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseA23.0964,8681,497,80264,868
Mar 17 2021LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USGrantA32.7614,652480,00049,50334.9 K to 49.5 K (+42.04 %)
Jul 20 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseM18.0413,343240,70833,542
Jul 20 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseM19.489,405183,2090
Jul 20 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS37.0013,343493,69134,55447.9 K to 34.6 K (-27.86 %)
Jul 20 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USBuyM18.0413,343240,70847,89734.6 K to 47.9 K (+38.61 %)
Jul 20 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS37.009,405347,98534,55444 K to 34.6 K (-21.39 %)
Jul 20 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USBuyM19.489,405183,20943,95934.6 K to 44 K (+27.22 %)
Jul 17 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseM15.9337,252593,4240
Jul 17 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS34.5037,2521,285,29834,55471.8 K to 34.6 K (-51.88 %)
Jul 17 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USBuyM15.9337,252593,42471,46234.2 K to 71.5 K (+108.89 %)
Jul 17 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseM15.9337,252593,4240
Jul 17 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS34.5037,2521,285,29834,55471.8 K to 34.6 K (-51.88 %)
Jul 17 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USBuyM15.9337,252593,42471,46234.2 K to 71.5 K (+108.89 %)
Mar 13 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseA24.4318,888461,43418,888
Mar 13 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USGrantA23.098,661199,98234,21025.5 K to 34.2 K (+33.90 %)
Mar 13 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USPayment of ExerciseF23.0987820,27325,54926.4 K to 25.5 K (-3.32 %)
Mar 13 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USPayment of ExerciseF27.1177621,03726,42727.2 K to 26.4 K (-2.85 %)
Feb 21 2020LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS23.536,090143,29727,20333.3 K to 27.2 K (-18.29 %)
Mar 14 2019LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseA21.9822,529495,18722,529
Mar 14 2019LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USGrantA24.437,163174,99232,62225.5 K to 32.6 K (+28.14 %)
Mar 14 2019LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USPayment of ExerciseF24.4344210,79824,88025.3 K to 24.9 K (-1.75 %)
Mar 14 2019LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USPayment of ExerciseF24.1478218,87725,32226.1 K to 25.3 K (-3.00 %)
Jun 01 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseM21.363,13266,9000
Jun 01 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseM17.245,973102,9750
Jun 01 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS27.756,451179,01526,10432.6 K to 26.1 K (-19.82 %)
Jun 01 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS27.751,46640,68232,55534 K to 32.6 K (-4.31 %)
Jun 01 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS27.753,13286,91334,02137.2 K to 34 K (-8.43 %)
Jun 01 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USSellS27.755,973165,75137,15343.1 K to 37.2 K (-13.85 %)
Jun 01 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USBuyM21.363,13266,90043,12640 K to 43.1 K (+7.83 %)
Jun 01 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USBuyM17.245,973102,97539,99434 K to 40 K (+17.56 %)
Mar 15 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USGrantA21.987,279159,99234,02126.7 K to 34 K (+27.22 %)
Mar 15 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USPayment of ExerciseF21.981,05723,23326,74227.8 K to 26.7 K (-3.80 %)
Mar 15 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USPayment of ExerciseF21.7378216,99327,79928.6 K to 27.8 K (-2.74 %)
Mar 12 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USOption ExerciseA18.0446,885845,80546,885
Mar 12 2018LMNXLUMINEX CORPCollins Charles J.SR VP, R&D - USPayment of ExerciseF21.062755,79228,58128.9 K to 28.6 K (-0.95 %)

Page:   1